Reply to the Editor – Regarding swallowing-induced atrial tachycardia arising from superior vena cava: Significant involvement of parasympathetic nerve activity  by Higuchi, Koji et al.
LETTERS TO THE EDITORTo the Editor—Swallowing-induced atrial
tachycardia arising from superior vena
cava: signiﬁcant involvement of
parasympathetic nerve activityWe read with great interest the case report of swallowing-
induced atrial tachycardia (AT) by Higuchi et al.1 The
arrhythmia was refractory to pharmacologic treatment;
however, the drugs used were not speciﬁed. Subsequently,
an electrophysiological study was performed and the
swallowing-induced focal trigger was localized in the super-
ior vena cava and was successfully ablated.
We would like to share our case of a 71-year-old man with
1-month history of swallowing-induced syncope. Short bursts
of presyncope inducing AT during swallowing were recorded
at lunch time. We found no pathology on echocardiography,
stress testing, or upper gastrointestinal barium swallow study.
Drug treatment with beta blockers was ineffective. Because
the mechanism of swallowing-induced syncope was pre-
sumed to be vagally mediated, we attempted treating the
patient with disopyramide owing to its vagolytic properties,
as was already decribed in the literature [2]. After 2 days of
therapy with slow-release disopyramide 250 mg twice a day,
the patient reported complete abolition of symptoms. To
conﬁrm the causal effect, the drug was discontinued and the
symptoms recurred almost immediately. Three months after
hospital discharge we contacted the patient and found out that
he stopped taking the medication and did not experience any
palpitations or syncope. We conﬁrmed the complete absence
of AT with 72-hour Holter monitoring.
Several case reports in the literature address effective
pharmacologic therapy of swallowing-induced arrhythmias
with remissions lasting even after its termination.2–4 There-
fore, we would like to stress that in similar cases treatment
should be principally focused on antiarrhythmic drugs with
known vagolytic action, since spontaneous remissions are
possible and catheter ablation is an invasive procedure with
few, but potentially serious, complications.
Bor Antolic, MD, PhD
bor.antolic@kclj.si
David Zizek, MD, PhD
Department of Cardiology
University Medical Centre Ljubljana
Ljubljana, Slovenia
References
1. Higuchi K, Hirao K, Hachiya H, Isobe M. Swallowing-induced atrial tachycardia
arising from superior vena cava: signiﬁcant involvement of parasympathetic nerve
activity. Heart Rhythm Case Reports 2016;2:306–309.
2. Malik A, Ali SS, Rahmatullah A. Deglutition-induced atrial ﬁbrillation. Tex Heart
Inst J 2005;32(4):602–604.2214-0271 B 2016 Heart Rhythm Society. Published by Elsevier Inc. This is an o
(http://creativecommons.org/licenses/by-nc-nd/4.0/).3. Baman NS, Baman TS, Taddonio W. Swallowing induced atrial ﬁbrillation.
Pacing Clin Electrophysiol 2004;27(4):555–556.
4. Kanjwal Y, Imran N, Grubb B. Deglutition induced atrial tachycardia and atrial
ﬁbrillation. Pacing Clin Electrophysiol 2007;30(12):1575–1578.Reply to the Editor – Regarding
swallowing-induced atrial tachycardia
arising from superior vena cava:
Signiﬁcant involvement of parasympathetic
nerve activityWe appreciate Drs Antolic and Zizek for giving us great
comments regarding our case of swallowing-induced atrial
tachycardia.1 With great interest, we read the case shown in
the letter.2 Because this arrhythmia was known to relate to
autonomic nerve activity and there were case reports in which
beta blockers or class Ia antiarrhythmic drugs with vagolytic
properties were effective,3 we tried bisoprolol, carvedilol, and
disopyramide for this patient. However, all drugs were
refractory to this arrhythmia and the patient was quite
symptomatic, as this arrhythmia occurred almost every time
he swallowed. Therefore, according to several reports of
swallowing atrial tachycardia that can be treated by catheter
ablation,4,5 we undertook this procedure with the patient as a
curative therapy as soon as possible. The case that Drs Antolic
and Zizek showed was very interesting and gave us important
input regarding treatment of swallowing-induced atrial tachy-
cardia. However, we still do not know who can be treated
using antiarrhythmic drugs or how long we should use
antiarrhythmic drugs. Also, the effect of antiarrhythmic drugs
is not stable. Therefore, we should consider catheter ablation
as soon as possible when antiarrhythmic drugs are ineffective,
since the success rate of catheter ablation is very high.
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